|
IM-MV 22-014_000
|
Prinses Máxima Centrum
|
A dose-escalation and dose-expansion study of the safety and efficacy of anti-CD7 allogeneic CAR-T cells (WU-CART-007) in patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T ALL)/lymphoblastic lymphoma (LBL)
|
21-12-2022
|
Vergunning verleend
|
